ENDOvascular Interventions With AngioMAX: The ENDOMAX Trial

Trial Profile

ENDOvascular Interventions With AngioMAX: The ENDOMAX Trial

Discontinued
Phase of Trial: Phase III

Latest Information Update: 02 Jun 2017

At a glance

  • Drugs Bivalirudin (Primary) ; Heparin
  • Indications Thrombosis
  • Focus Registrational; Therapeutic Use
  • Acronyms ENDOMAX
  • Sponsors The Medicines Company
  • Most Recent Events

    • 21 Apr 2017 Status changed from active, no longer recruiting to discontinued.
    • 05 Oct 2015 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
    • 03 Feb 2015 Planned primary completion date changed from 1 Mar 2015 to 1 Dec 2016 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top